Back

MindMaze Therapeutics sets 2026 schedule for investor and industry conferences

Verifying
  • MindMaze Therapeutics announced participation in investor and industry conferences across the United States and Europe.
  • September 21, 2026 marks the company’s Baader Investment Conference presentation in Munich.
  • MindMaze will exhibit neurotechnology solutions and present real-world evidence at four industry conferences.
The information on this website is generated using AI and we cannot guarantee its accuracy. Please use it as reference information only.